Psychopharmacology

, Volume 125, Issue 4, pp 285–345 | Cite as

The biological, social and clinical bases of drug addiction: commentary and debate

  • J. Altman
  • B. J. Everitt
  • T. W. Robbins
  • S. Glautier
  • A. Markou
  • D. Nutt
  • R. Oretti
  • G. D. Phillips
Review

Abstract

This article summarizes the main discussions at a meeting on the biological, social and clinical bases of drug addiction focused on contemporary topics in drug dependence. Four main domains are surveyed, reflecting the structure of the meeting: psychological and pharmacological factors; neurobiological substrates; risk factors (including a consideration of vulnerability from an environmental and genetic perspective); and clinical treatment. Among the topics discussed were tolerance, sensitization, withdrawal, craving and relapse; mechanisms of reinforcing actions of drugs at the behavioural, cognitive and neural levels; the role of subjective factors in drug dependence; approaches to the behavioural and molecular genetics of drug dependence; the use of functional neuroimaging; pharmaceutical and psychosocial strategies for treatment; epidemiological and sociological aspects of drug dependence. The survey takes into account the considerable disagreements and controversies arising from the discussions, but also reaches a degree of consensus in certain areas.

Key words

Dependence Addiction Drug abuse Craving Relapse Tolerance Sensitization Withdrawal Opponent process theories Subjective Discriminative effects Reinforcement Habit Neural systems Psychomotor stimulants Amphetamine Cocaine Oppiates Alcohol Nicotine Hallucinogens Amygdala Stratum Nucleus accumbens Dopamine 5-HT Cerebral cortex Functional neuroimaging PET Transcription factors Behavioural genetics Strain-dependent effects Quantitative trait loci Individual differences Risk factors Personality and dependence Biological markers of dependence Co-morbidity Schizophrenia Depression Pharmacological treatment for dependence Psychosocial treatment of dependence Sociology of dependence Epidemiology of dependence Animal models of dependence 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abrams DB, Monti PB, Carey KB, Pinto RP, Jacobus SI (1988) Reactivity to smoking cues and relapse: two studies of discriminant validity. Behav Res Ther 26: 225–233Google Scholar
  2. Acquas E, Di Chiara G (1992) Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. J Neurochem 58: 1620–1625Google Scholar
  3. Acquas E, Di Chiara G (1994) D1 receptors blockade stereospecifically impairs the acquisition of drug-conditioned place-preference and place-aversion. Behav Pharmacol 5: 555–569Google Scholar
  4. Alheid GF, Heimer L (1988) New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid and corticopetal components of the substantia innominata. Neuroscience 27: 1–39Google Scholar
  5. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington DCGoogle Scholar
  6. Amit Z, Smith BR, Sutherland EA (1987) Oral self-administration of alcohol: a valid approach to the study of drug self-administration and human alcoholism. In: Bozarth M (ed) Methods of assessing the reinforcing properties of abused drugs. Springer, New York Berlin Heidelberg, pp 161–172Google Scholar
  7. Antelman SM, Eichler AJ, Black CA, Kocan D (1980) Interchangeability of stress and amphetamine in sensitization. Science 207: 329–331Google Scholar
  8. Ator NA, Griffiths RR (1993) Differential sensitivity to midazolam discriminative-stimulus effects following self-administered versus response-independent midazolam. Psychopharmacology 110: 1–4Google Scholar
  9. Baker TB, Morse E, Sherman JE (1986) The motivation to use drugs: a psychobiological analysis of urges. Nebraska Symposium on Motivation, Univ Nebraska Press, pp 257–323Google Scholar
  10. Becker HC (1994) Positive relationship between the number of prior ethanol withdrawal episodes and the severity of subsequent withdrawal seizures. Psychopharmacology 116: 26–32Google Scholar
  11. Begleiter M, Oorjesz B, Bihari B, Kissin B (1984) Event-related brain potentials in boys at risk for alcoholism. Science 227: 1493–1496Google Scholar
  12. Beninger RJ (1983) The role of dopamine in locomotor activity and learning. Brain Res Rev 6: 173–196Google Scholar
  13. Benkelfat C, Murphy DL, Hill JL, George TD, Nutt DJ, Linnoila M (1991) Ethanol-like properties of the serotonergic partial agonist m-chlorophenylpiperazine in chronic alcoholic patients. Arch Gen Psychiatry 48: 383Google Scholar
  14. Benowitz NL, Porchet H, Jacob P III (1989) Nicotine and tolerance in man: Pharmacokinetic and pharmacodynamic investigations. Prog Brain Res 79: 279–287Google Scholar
  15. Bickel WK, DeGrandpre RJ, Higgins ST (1995) The behavioural economics of concurrent drug reinforcement: a review and reanalysis of drug self-administration research. Psychopharmacology 118: 250–259Google Scholar
  16. Blum K, Noble EP, Sheridan PJ, et al. (1990) Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 263: 2055–2060Google Scholar
  17. Bouton ME, Swatzentruber D (1991) Sources of relapse after extinction in Pavlovian and instrumental learning. Clin Psychol Rev 11: 123–140Google Scholar
  18. Bozarth MA, Wise RA (1984) Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science 224: 516–517Google Scholar
  19. Bridger WH (1978) Good trip or bad trip: the role of tolerance and stress in hallucinogenic drug action. Adv Biochem Psychopharmacol 13: 1–25Google Scholar
  20. Buck KJ, Harris RA (1991) Neuroadaptive responses to chronic ethanol. Alcohol Clin Exp Res 15: 460–470Google Scholar
  21. Buck KJ, Heim H, Harris RA (1991) Reversal of alcohol dependence and tolerance by a single administration of flumazenil. J Pharmacol Exp Ther 257: 984–989Google Scholar
  22. Burns LH, Robbins TW, Everitt BJ (1993) Differential effects of excitotoxic lesions of the basolateral amygdala, ventral subiculum and medial prefrontal cortex on responding with conditioned reinforcement and locomotor activity potentiated by intra-accumbens infusions of D-amphetamine. Behav Brain Res 55: 167–183Google Scholar
  23. Cador M, Robbins TW, Everitt BJ (1989) Involvement of the amygdala in stimulus-reward associations: interaction with the ventral striatum. Neuroscience 30: 77–86Google Scholar
  24. Carlen PL, Gurevich N, Polc P (1993) Low-dose benzodiazepine neuronal inhibition: enhanced Ca2+-mediated K+ conductance. Brain Res 27: 358–364Google Scholar
  25. Caroll KM, Rounsaville BJ, Keller DS (1991) Relapse prevention strategies for the treatment of cocaine abuse. Am J Drug Alcohol Abuse 17: 249–265Google Scholar
  26. Carrera MRA, Ashley JA, Parsons LH, Witsching P, Koob GF, Janda KD (1995) Suppression of psychoactive effects of cocaine by active immunization. Nature 378: 727–730Google Scholar
  27. Carroll ME (1996) Interactions between food and addiction. In: Niesink RJM, Kornet MLMW (eds) Behavioral toxicology and addiction: food, drugs and environment. Open University Press, The NetherlandsGoogle Scholar
  28. Carroll ME, Meisch R (1979) Concurrent etonitazene and water intake in rats: roles of taste, olfaction, and auditory stimuli. Psychopharmacology 64: 1–7Google Scholar
  29. Chang J-Y, Sawyer SF, Lee R-S, Woodward DJ (1994) Electrophysiological and pharmacological evidence for the role of the nucleus accumbens in cocaine self-administration in freely moving rats. J Neurosci 14: 1224–1244Google Scholar
  30. Chilcoat HD, Anthony JC (1996) Hypothesized impact of parent monitoring on initiation of drug use through late childhood. Pediatrics (in press)Google Scholar
  31. Chilcoat HD, Dishion TJ, Anthony JC (1995) Parent monitoring and incidence of early drug sampling in urban elementary school children. Am J Epidemiol 141: 25–31Google Scholar
  32. Childress AR, Ehrman R, Roohsenow DJ, Robbins SJ, O'Brien CP (1992) Classically conditioned factors in drug dependence. In: Lowinson W, Luiz P, Millman RB, Langard JG (eds) Substance abuse: a comprehensive textbook. Williams and Wilkins, Baltimore, pp 56–69Google Scholar
  33. Church WH, Justice JB Jr (1989) On-line small-bore chromatography for neurochemical analysis in the brain. In: Gidding JC, Grushka E, Brown PR (eds) Advances in chromatography. Dekker, New York, pp 165–194Google Scholar
  34. Clayton RR (1986) Multiple drug use: epidemiology, correlates and consequences. In: Galanter M (ed) Recent developments in alcoholism, vol IV. Plenum, New York, pp 7–38Google Scholar
  35. Cloninger CR (1987) Neurogenetic adaptive mechanisms in alcoholism. Science 236: 410–416Google Scholar
  36. Cloninger CR (1994) Temperament and personality. Curr Opin Neurobiol 4: 266–273Google Scholar
  37. Cohen S, Lichtenstein E (1990) Perceived stress, quitting smoking and smoking relapse. Health Psychol 9: 466–478Google Scholar
  38. Courtwright D, Joseph H, Des Jalais D (1989) Addicts who survived: an oral history of narcotic use in America 1923–1965. University of Tennessee Press, Knoxville, pp 1–44Google Scholar
  39. Cowley DS, Roy-Byrne PP, Godon C, Greenblatt DJ, Reis R, Walker RD, Samson H, Hommer DW (1992) Response to diazepam in sons of alcoholics. Alcohol Clin Exp Res 16: 1057–1063Google Scholar
  40. Cowley DS, Roy-Byrne PP, Greenblatt DJ, Homer DW (1993) Personality and benzodiazepine sensitivity in anxious patients and control subjects. Psychiatry Res 47: 151–162Google Scholar
  41. Crabbe JC, Belknap JK (1992) Genetic approaches to drug dependence. Trends Pharmacol Sci 13: 212–219Google Scholar
  42. Crabbe JC, Li T-K (1995) Genetic strategies in preclinical substance abuse research. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 799–811Google Scholar
  43. Crabbe JC, Phillips TJ (1993) Selective breeding for alcohol withdrawal severity. Behav Genet 23: 169–175Google Scholar
  44. Crabbe JC, Belknap JK, Buck KJ (1994) Genetic animal models of alcohol and drug abuse. Science 264: 1715–1723Google Scholar
  45. Crippens D, Robinson TE (1994) Withdrawal from morphine or amphetamine: different effects on dopamine in the ventral-medial stratum studied with microdialysis. Brain Res 650: 56–62Google Scholar
  46. Crippens D, Camp DM, Robinson TE (1993) Basal extracellular dopamine in the nucleus accumbens during amphetamine withdrawal: a ‘no net efflux’ microdialysis study. Neurosci Lett 164: 145–148Google Scholar
  47. Cunningham CL (1995) Localization of genes influencing ethanol-induced conditioned place preference and locomotor activity in BXD recombinant inbred mice. Psychopharmacology 120: 28–41Google Scholar
  48. Davis WM, Smith SG (1987) Conditioned reinforcement as a measure of the rewarding properties of drugs. In: Bozarth M (ed) Methods of assessing the reinforcing properties of abused drugs. Springer Berlin Heidelberg, New York, pp 199–210Google Scholar
  49. Dawe S, Powell J, Richards D, Gossop M, Strang J, Marks I, Gray J (1993) Does post-withdrawal cue exposure improve outcome in opiate addiction? A controlled trial. Addiction 88: 1233–1245Google Scholar
  50. DeGrandpre RJ, Bickel WK, Rizvi SAT, Hughes JR (1993) The behavioural economics of drug self-administration. VII. Effects of income on drug choice in humans. J Exp Anal Behav 59: 483–500Google Scholar
  51. Devor EJ, Cloninger CR, Hoffman PL, Tabakoff B (1991) Genetic study of platelet adenylyl cyclase activity: evidence for a single major locus effect in fluoride-stimulated activity. Am J Hum Genet 49: 372–377Google Scholar
  52. Devor EJ, Abell CW, Hoffman PL, Tabakoff B, Cloninger CR (1994) Platelet MAO activity in type I and type II alcoholism. Ann NY Acad Sci 708: 119–128Google Scholar
  53. Diana M, Pistis M, Carboni S, Gessa GL, Rossetti ZL (1993) Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence. Proc Natl Acad Sci USA 90: 7966–7969Google Scholar
  54. Di Chiara G (1990) In vivo brain dialysis of neurotransmitters. Trends Pharmacol Sci 11: 116–121Google Scholar
  55. Di Chiara G (1995) The role of dopamine in drug-abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 38: 95–137Google Scholar
  56. Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85: 5274–5278Google Scholar
  57. Di Chiara G, North RA (1992) Neurobiology of opiate abuse. Trends Pharmacol Sci 13: 185–193Google Scholar
  58. Di Ciano P, Blaha CD, Phillips AG (1995a) Conditioned increases in motor activity and dopamine concentrations in the nucleus accumbens of the rat following repeated administration of cocaine or d-amphetamine. Neurosci Abstr 21: 826.4Google Scholar
  59. Di Ciano P, Coury A, Depoortere RY, Egilmez Y, Lane JD, Emmett-Oglesby MW, LePiane FG, Phillips AG, Blaha CD (1995b) Comparison of changes in extracellular dopamine concentrations in the nucleus accumbens during intravenous self-administration of cocaine or d-amphetamine. Behav Pharmacol 6: 311–322Google Scholar
  60. Dickinson A (1994) Instrumental conditioning. In: Mackintosh NJ (ed) Animal learning and cognition. Academic Press, San Diego, pp 45–79Google Scholar
  61. Doty P, Wit H de (1995) Effect of setting in the reinforcing and subjective effects of ethanol in social drinkers. Psychopharmacology 118: 19–27Google Scholar
  62. Drummond DC, Glautier S (1994) A controlled trial of cue exposure treatment in alcohol dependence. J Consult Clin Psychol 62: 809–817Google Scholar
  63. Drummond DC, Tiffany ST, Glautier S, Remington B (eds) (1995) Addiction: cue exposure, theory and practice. Wiley, LondonGoogle Scholar
  64. Dworkin SI, Guerin GF, Goeders NE, Cherek DR, Lane JD, Smith JE (1984) Reinforcer interactions under concurrent schedules of food, water, and intravenous morphine. Psychopharmacology 82: 282–286Google Scholar
  65. Dworkin SI, Porrino LJ, Smith JE (1992) Importance of behavioural controls in the analysis of ongoing events. NIDA Res Monogr 124: 173–188Google Scholar
  66. Dworkin SI, Co C, Smith JE (1995a) Rat brain neurotransmitter turnover rates altered during withdrawal from chronic cocaine administration. Brain Res 682: 116–126Google Scholar
  67. Dworkin, SI, Mirkis, S, Smith JE (1995b) Response-dependent versus response-independent presentation of cocaine: differences in the lethal effects of the drug. Psychopharmacology 117: 262–266Google Scholar
  68. Ehrman RN, Robbins SJ, Childress AR, McLellan AT, O'Brien CP (1992a) Responding to drug-related stimuli in humans as a function of drug history. NIDA Res Monogr 116: 231–244Google Scholar
  69. Ehrman P, Terne J, O'Brien CP, McLellan AT (1992b) Conditioned tolerance in human opiate addicts. Psychopharmacology 108: 208–224Google Scholar
  70. Elkins RL (1991) An appraisal of chemical aversion (emetic therapy) approaches to alcoholism treatment. Behav Res Ther 29(5): 387–413Google Scholar
  71. Elsmore TF, Fletcher GV, Conrad DG, Sodetz FJ (1980) Reduction of heroin intake in baboons by economic constraints. Pharmacol Biochem Behav 13: 729–731Google Scholar
  72. Emmett-Oglesby MW, Peltier RL, Depoortere RY, Pickering CL, Hooper ML, Gong YH, Lane JD (1993) Tolerance to self-administration of cocaine in rats: time course and dose-response determination using a multi-dose method. Drug Alcohol Depend 32: 247–256Google Scholar
  73. Enoch MA, Rohrhaugh JW, Davis EZ, Harris C, Ellington RJ, Andreason P, Moor V, Varner JL, Brown GL, Eckardt MJ, Goldman D (1996) Genetic epidemiology and relationship to psychopathology of the low voltage and monomorphic alpha variants of the electroencephalogram. Neuropsychiatr Genet (in press)Google Scholar
  74. Erb SM, Parker LA (1994) Individual differences in novelty-induced activity do not predict strength of amphetamine-induced place conditioning. Pharmacol Biochem Behav 48: 581–586Google Scholar
  75. Esposito E, Kruszewska A, Ossowska G, Samanin R (1987) Noradrenergic and behavioural effects of naloxone injected in the locus coeruleus of morphine-dependent rats and their control by clonidine. Psychopharmacology 93: 393–396Google Scholar
  76. Everitt BJ, Robbins TW (1992) Amygdala-ventral striatal interactions and emotional behaviour. In: Aggleton J (ed) The amygdala: neurobiological aspects of emotion, memory and mental dysfunction. Wiley, New York, pp 401–429Google Scholar
  77. Everitt BJ, Morris KA, O'Brien A, Robbins TW (1991) The basolateral amygdala-ventral striatal system and conditioned place preference: further evidence of limbic-striatal interactions underlying reward-related processes. Neuroscience 42: 1–18Google Scholar
  78. Everitt BJ, Schulteis G, Koob GF (1993) Attenuation of conditioned opiate withdrawal following excitotoxic lesions of the basolateral amygdala. Soc Neurosci Abstr 19/2: 511.5Google Scholar
  79. Eysenck HJ (1963) Experiments with drugs. Macmillan, New YorkGoogle Scholar
  80. Falk J (1961) Production of polydipsia in normal rats by an intermittent food schedule. Science 133: 195–196Google Scholar
  81. Farrell M, Ward J, Mattick, R, Hall W, Stimson GV, Des Jarlais D, Gossop M, Strang J (1994) Methadone maintenance treatment in opiate dependence: a review. Br Med J 309: 997–1001Google Scholar
  82. Fibiger HC (1993) Mesolimbic dopamine: an analysis of its role in motivated behavior. Semin Neurosci 5: 321–327Google Scholar
  83. Finlay JM, Damsma G, Fibiger HC (1992) Benzodiazepine-induced changes in extracellular concentrations of dopamine in the nucleus accumbens after acute and repeated administration. Psychopharmacology 106: 202–208Google Scholar
  84. Fischman M, Foltin R (1992) Self-administration of cocaine by humans: a laboratory perspective. Ciba Found Symp 166: 165–180Google Scholar
  85. Fischman MW, Foltin RW, Pearlson G, Nestadt G (1990) Effects of desipramine maintenance on cocaine self-administration. J Pharmacol Exp Ther 253: 760–770Google Scholar
  86. Foltin RW, Fischman MW (1994) Effects of buprenorphine on the self-administration of cocaine by humans. Behav Pharmacol 5: 79–89Google Scholar
  87. Fulco C, Liverman C, Early L (eds) (1994) Development of antiaddiction medications: issues for the government and private sector. Institute of Medicine, Washington DCGoogle Scholar
  88. Fulco C, Liverman C, Early L (eds) (1995) Development of medications for the treatment of opiate and cocaine addiction: issues for the government and private sector. Institute of Medicine, Washington DCGoogle Scholar
  89. Fuller RK, Branchey L, Brightwell DR, et al (1989) Disulfiram treatment of alcoholism: a Veterans Administration Cooperative study. JAMA 256: 1449–1455Google Scholar
  90. Gawin FH (1991) Cocaine addiction: psychology and neurophysiology. Science 251: 1580–1586Google Scholar
  91. Gawin FH, Kleber H (1986) Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch Gen Psychiatr 43: 107–113Google Scholar
  92. Geyer MA, Markou A (1995) Animal models of psychiatric disorders. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 787–798Google Scholar
  93. Glassman AH (1993) Cigarette smoking: implications for psychiatric illness. Am J Psychiatry 150: 546–553Google Scholar
  94. Glassman AH, Helzer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, Johnson J (1990) Smoking, smoking cessation, and major depression. JAMA 264: 1546–1549Google Scholar
  95. Glautier S, Drummond DC (1994) Alcohol dependence and cue reactivity. J Stud Alcohol 55: 224–229Google Scholar
  96. Gold LH, Stinus L, Inturrisi CE, Koob GF (1994) Prolonged tolerance, dependence, and abstinence following subcutaneous morphine pellet implantation in the rat. Eur J Pharmacol 253: 45–51Google Scholar
  97. Goldberg SR, Schuster CR (1967) Conditioned suppression by a stimulus associated with nalorphine in morphine-dependent monkeys. J Exp Anal Behav 10: 235–242Google Scholar
  98. Goldberg SR, Spealman R (1982) Maintenance and suppression of behavior by intravenous nicotine injections in squirrel monkeys. Fed Proc 41: 216–220Google Scholar
  99. Goldberg SR, Hoffmeister F, Schlichting U, Wuttke W (1971) Aversive properties of nalorphine and naloxone in morphine-dependent rhesus monkeys. J Pharmacol Exp Ther 179: 268–276Google Scholar
  100. Goldberg SR, Woods JH, Schuster CR (1969) Morphine: conditioned increases in self-administration in rhesus monkeys. Science 166: 1306–1307Google Scholar
  101. Goldman D, Dean M, Brown GI, Bolos AM, Tokola R, Virkkunen M, Linnoila M (1992) D2 dopamine receptor genotype and cerebrospinal fluid homovanillic acid, 5-hydroxyindoleacetic acid and 3-methoxy-4-hydroxyphenylglycol in alcoholics in Finland and the United States. Acta Psychiatr Scand 86: 351–357Google Scholar
  102. Goudie AJ (1987) Aversive stimulus properties of drugs: the conditioned taste aversion paradigm. In: Dourish CT, Greenshaw AJ (eds) Experimental approaches in psychopharmacology. Humana Press, NJ, pp 341–391Google Scholar
  103. Goudie AJ (1991) Animal models of drug abuse and dependence. In: Willner P (ed) Behavioural models in psychopharmacology: Theoretical, industrial and clinical perspectives. Cambridge University Press, Cambridge, pp 453–484Google Scholar
  104. Goudie AJ, Emmett-Oglesby MW (eds) (1989) Psychoactive drugs: tolerance and sensitization. Humana Press, NJGoogle Scholar
  105. Grant BF (1989) DSM III-R and ICD 10 classifications of alcohol use disorders and associated disabilities: a structural analysis. Int Rev Psychiatry 1: 21–39Google Scholar
  106. Grant K, Samson H (1985) Induction and maintenance of ethanol self-administration without food deprivation in the rat. Psychopharmacology 86: 475–479Google Scholar
  107. Griffiths RR, Wurster RM, Brady JV (1981) Choice between food and heroin: effects of morphine, naloxone, and secobarbital. J Exp Anal Behav 35:335–351Google Scholar
  108. Groenewegen HJ, Berendse HW, Wolter JG, Lohman AHM (1990) The anatomical relationship of the prefrontal cortex with the striatopallidal system, the thalamus and the amygdala: evidence for a parallel organization. Prog Brain Res 85:95–118Google Scholar
  109. Groves PT, Thompson RF (1970) Habituation: a dual process theory. Psychol Rev 77:419–450Google Scholar
  110. Harris GC, Aston-Jones G (1994) Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature 371:155–157Google Scholar
  111. Harris RA, Buck KJ (1990) The processes of alcohol tolerance and dependence. Alcohol Health Res World 14:105–110Google Scholar
  112. Hawkins JD, Catalano RF, Miller JY (1992) Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psychol Bull 112:64–105Google Scholar
  113. Hearn WL, Flynn DD, Hime GW, Rose S, Cofino JC, Mantero-Atienza E, Wetli CV, Mash DC (1991) Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter. J Neurochem 56:698–701Google Scholar
  114. Heimer L, Zahm DS, Alheid GF (1995) Basal ganglia. In: Paxinos G (ed) The rat nervous system. Academic Press, Sydney, pp 579–628Google Scholar
  115. Herberg LJ, Montgomery AMJ, Rose IC (1993) Tolerance and sensitization to stimulant and depressant effects of nicotine in intra-cranial self-stimulation. Behav Pharmacol 4:419–428Google Scholar
  116. Hernandez L, Tucci S, Guzman N, Paez X (1993) “In vivo” monitoring of glutamate in the brain by microdialysis and capillary electrophoresis with laser-induced fluorescence detection. J Chromatogr 652:393–398Google Scholar
  117. Herrnstein RJ, Prelec D (1992) A theory of addiction. In: Loewenstein G, Elster J (eds) Choice over time. Russell Sage Foundation, New York, pp 331–360Google Scholar
  118. Heyman GM (1996) Resolving the contradictions of addiction. Behav Brain Sci (in press)Google Scholar
  119. Higgins ST, Budney AJ, Bickel WK, Foerg FE, Donham MA, Badger GJ (1994) Incentives improve outcome in outpatient behavioural treatment for cocaine dependence. Arch Gen Psychiatry 51:568–576Google Scholar
  120. Higley JD, Hasert MF, Suomi SJ, Linnoila M (1991) Nonhuman primate model of alcohol abuse: effects of early experience, personality, and stress on alcohol consumption. Proc Natl Acad Sci USA 88:7261–7265Google Scholar
  121. Hirst W (1995) Cognitive aspects of consciousness. In: Gazzaniga M (ed) The cognitive neurosciences. MIT Press, Cambridge, Mass, pp 1307–1319Google Scholar
  122. Hodgkinson S, Mullan M, Murray RM (1991) The genetics of vulnerability to alcoholism. In: McGuffin P, Murray R (eds) The new genetics of mental illness. Mental Health Foundation, London, pp 182–197Google Scholar
  123. Hodos W (1961) Progressive ratio as a measure of reward strength. Science 134:943–944Google Scholar
  124. Hooks MS, Duffy P, Striplin C, Kalivas PW (1994) Behavioural and neurochemical sensitization following cocaine self-administration. Psychopharmacology 115:265–272Google Scholar
  125. Horger BA, Giles MK, Schenk S (1992) Pre-exposure to amphetamine and nicotine predisposes rats to self-administer a low dose of cocaine. Psychopharmacology 107:271–276Google Scholar
  126. Howes SR, Wilkinson LS, Robbins TW, Everitt BJ (1995) Isolation-rearing both enhances and retards the acquisition of intravenous cocaine self-administration depending on training dose: a behavioural and in vivo dialysis study. Soc Neurosci Abstr. 21:285.15Google Scholar
  127. Iglauer C, Woods JH (1974) Concurrent performances: reinforcement by different doses of intravenous cocaine in rhesus monkeys. J Exp Anal Behav 22:179–196Google Scholar
  128. Isbell H, Belleville RE, Fraser HF, Wikler A, Logan CR (1956) Studies in lysergic acid diethylamide (LSD-21). Effects in former morphine addicts and development of tolerance during chronic intoxication. AMA Arch Neurol Psychiatry 76:468–478Google Scholar
  129. Jaffe JH (1990) Drug addiction and drug abuse. In: Gilman AG, Rall TW, Nies AS, Taylor P (eds) Goodman and Gilman's the pharmacological basis of therapeutics. Pergamon, New York, pp 522–573Google Scholar
  130. Johanson CE, Duffy FF, Anthony J (1996) Associations between drug use and behavioural repertoires in urban youths. Addiction (in press)Google Scholar
  131. Joyce PR, Mulder RT, Cloninger CR (1994) Temperament predicts clomipramine and imipramine response in depressed patients. J Affect Disord 30:35–46Google Scholar
  132. Jönsson L, Änggard E, Gunne L (1971) Blockade of amphetamine euphoria in man. Clin Pharmacol Ther 12:889–896Google Scholar
  133. Kalant H, LeBlanc AE, Gibbons RJ (1971) Tolerance to, and dependence on, some non-opiate sychotrophic drugs. Pharmacol Rev 23:135–191Google Scholar
  134. Kalivas PW, Duffy P (1993) Time course of extracellular dopamine and behavioural sensitization to cocaine. I. Dopamine axon terminals. J Neurosci 13:266–275Google Scholar
  135. Karler R, Calder LD, Chaudhry IA, Turkanis SA (1989) Blockade of “reverse tolerance” to cocaine and amphetamine by MK-801. Life Sci 45:599–606Google Scholar
  136. Katz J, Goldberg SR (1987) Second-order schedules of drug injection. In: Bozarth M (ed) Methods of assessing the reinforcing properties of abused drugs. Springer, New York Berlin Heidelberg, pp 105–115Google Scholar
  137. Kellam SG, Simon MB, Ensminger ME (1983) Antecedents in first grade of teeenage substance abuse and psychological well-being: a ten-year community-wide prospective study. In: Ricks RF, Dohrenwend BS (eds) Origins of psychopathology. Cambridge University Press, Cambridge, UK, pp 17–42Google Scholar
  138. Kelleher RT (1966) Chaining and conditioned reinforcement. In: Honig WK (ed) Operant behavior: areas of research and application. Appleton-Century-Crofts, New York, pp 160–212Google Scholar
  139. Kendler KS, Neale MC, MacLean CJ, Heath AC, Eaves LJ, Kessler RC (1993) Smoking and major depression: a causal analysis. Arch Gen Psychiatry 50:36–43Google Scholar
  140. Koelega HS (1995) Alcohol and vigilance performance: a review. Psychopharmacology 118:233–249Google Scholar
  141. Koob GF (1992) Neural mechanisms of drug reinforcement. Ann NY Acad Sci 654:171–191Google Scholar
  142. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715–723Google Scholar
  143. Koob GF, Goeders, NE (1989) Neuroanatomical substrates of drug self-administration. In: Liebman JM, Cooper SJ (eds) Neuropharmacological basis of reward. Oxford University Press, Oxford, pp 214–263Google Scholar
  144. Koob GF, Stinus L, LeMoal M, Bloom FE (1989) Opponent process theory of motivation: neurobiological evidence from studies of opiate dependence. Neurosci Biobehav Rev 13:135–140Google Scholar
  145. Koob GF, Maldonado R, Stinus L (1992) Neural substrates of opiate withdrawal. Trends Neursci 15:186–191Google Scholar
  146. Kranzler HR, Burleson JA, Del Boca FK, Babor TF, Korner P, Brown J, Bohn MJ (1994) Buspirone treatment of anxious alcoholics. Arch Gen Psychiatry 51:720–731Google Scholar
  147. Ksir CJ, Hakan RL, Kellar KJ (1987) Chronic nicotine and locomotor activity: influences of exposure dose and test dose. Psychopharmacology 92:25–29Google Scholar
  148. Kuhar MJ (1992) Molecular pharmacology of cocaine: a dopamine hypothesis and its implications. Ciba Found Symp 166:81–95Google Scholar
  149. Lamb RJ, Preston KL, Schindler CW, Meische RA, Davis F, Katz JL, Henningfield JE, Goldberg SR (1991) The reinforcing and subjective effects of morphine in post-addicts: a dose-response study. J Pharmacol Exp Ther 259:1165–1173Google Scholar
  150. Le AD (1990) Factors regulating alcohol tolerance. Ann Med 22:265–268Google Scholar
  151. LeDuc PA, Mittleman G (1995) Schizophrenia and psychomotor stimulant drug abuse: a review and re-analysis of the critical evidence. Psychopharmacology 121:407–427Google Scholar
  152. Lett BT (1989) Repeated exposures intensify rather than weaken the rewarding effects of amphetamine, morphine and cocaine. Psychopharmacology 98:357–362Google Scholar
  153. Lhuintre JP, Daoust M, Moore MD, et al (1990) Acamprosate appears to decrease alcohol intake in weaned alcoholics. Alcohol Alcohol 25:613–622Google Scholar
  154. Li DH, Depoorteere RY, Emmett-Oglesby MW (1994) Tolerance to the reinforcing effects of cocaine in a progressive ratio paradigm. Psychopharmacology 116:326–332Google Scholar
  155. Li T-K, Lumeng L, Doolittle DP (1993) Selective breeding for alcohol preference and associated responses. Behav Genet 23:163–170Google Scholar
  156. Linseman MA (1987) Alcohol consumption in free-feeding rats: procedural, genetic and pharmacokinetic factors. Psychopharmacology 92:254–261Google Scholar
  157. Lister RG, Nutt DJ (1987) Is RO 15-4513 a specific alcohol antagonist? Trends Neurosci 101:223–225Google Scholar
  158. Little HJ (1991) Mechanisms that may underlie the behavioural effects of ethanol. Prog Neurobiol 36:171–194Google Scholar
  159. Littlejohn J (1995) Acamprosate in alcohol dependence: how does it work? Addiction 90:1179–1188Google Scholar
  160. London ED (ed) (1993) Imaging drug action in the brain. CRC Press, Boca RatonGoogle Scholar
  161. London ED, Cascella NG, Wong DF, Phillips RL, Dannals RF, Links JM, Herning R, Grayson R, Jaffe JH, Wagner HNJr, (1990) Cocaine-induced reduction of glucose utilization in human brain — a study using positron emission tomography and [18F] fluorodeoxyglucose. Arch Gen Psychiat 47:567–574Google Scholar
  162. Markou A, Koob GF (1991) Post cocaine anhedonia. Neuropsychopharmacology 4:17–26Google Scholar
  163. Markou A, Weiss F, Gold LH, Caine SB, Schulteis G, Koob GF (1993) Animal models of drug craving. Psychopharmacology 112:163–182Google Scholar
  164. Marks MJ, Romm E, Campbell SM, Collins AC (1989a) Variation of nicotinic binding sites among inbred strains. Pharmacol Biochem Behav 33:679–689Google Scholar
  165. Marks MJ, Stitzel JA, Collins AC (1989b) Genetic influences on nictoine responses. Pharmacol Biochem Behav 33:667–678Google Scholar
  166. Marks MJ, Pauly JR, Gross SD, Deneris ES, Hermans-Borgmeyer, Heinemann SF, Collins AC (1992) Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci 12:2765–2784Google Scholar
  167. Marlatt GA, Gordon JR (1980) Departments of drug relapse. In: Davidson PO, Davidson SM (eds) Behavioural medicine: changing health lifestyles. Brunner/Mazel, New York, pp 410–452Google Scholar
  168. McAlonan GM, Robbins TW, Everitt BJ (1993) Effects of medial dorsal thalamic and ventral pallidal lesions on the acquisition of a conditioned place preference: further evidence for the involvement of the ventral striatopallidal system in reward-related processes. Neuroscience 52:605–620Google Scholar
  169. McGuffin P, Owen MJ, O'Donovan MC, Thapar A, Gottesman II (1994) Alcoholism. In: Seminars in Psychiatric Genetics. Gaskell Press, London, pp 161–173Google Scholar
  170. McLellan AT, O'Brien CP, Metzger D, Alterman AI, Cornish J, Urschel H (1992) How effective is substance abuse treatment — compared to what? In: O'Brien CP, Jafe J (eds) Addictive states, vol 14. Raven Press, New York, pp 231–252Google Scholar
  171. McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP (1993) The effects of psychosocial services in substance abuse treatment. JAMA 269:1953–1959Google Scholar
  172. McNair DM, Fisher S, Sussman C, Droppleman LF, Kahn RJ (1970) Persistence of a drug personality interaction in psychiatric outpatients. J Psychiat Res 7:299–305Google Scholar
  173. Meisch RA, Carroll M (1987) Oral drug self-administration: drugs as reinforcers. In: Bozarth M (ed) Methods of assessing the reinforcing properties of abused drugs. Springer, New York Berlin Heidelberg, pp 143–160Google Scholar
  174. Melchior CM, Tabakoff B (1985) Features of envionment-dependent tolerance to ethanol. Psychopharmacology 87:94–100Google Scholar
  175. Mello NK, Mendelson JH, Palmieri SL (1987) Cigarettte smoking by women: interactions with alcohol use. Psychopharmacology 93:8–15Google Scholar
  176. Meyer RE (1986) How to understand the relationship between psychopathology and addicitive disorders: another example of the chicken and the egg. In: Meyer RE (ed) Psychopathology and addictive disorders. Guilford Press, New York, pp 3–16Google Scholar
  177. Meyer RE, Mirin SM (1979) The heroin stimulus: implications for a theory of addiction. Plenum Press, New YorkGoogle Scholar
  178. Mogenson GJ, Yang CR (1991) The contribution of basal forebrain to limbic-motor integration and the mediation of motivation to action. Adv Exp Med Biol 295:267–290Google Scholar
  179. Murphy SM, Tyrer P (1991) A double blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence. Br J Psychiatry 158:511–516Google Scholar
  180. Myles J, Weinstein A (1996) Amphetamine prescribing: comparison with street stimulant use. J Psychopharmacol (in press)Google Scholar
  181. Musto DF (1991) Opium, cocaine and marijuana in American history. Sci Am 265:40–47Google Scholar
  182. Nagy LE, Diamond I, Gordon A (1988) Cultered lymphocytes from alcoholic subjects have altered cAMP signal transduction. Proc Natl Acad Sci USA 85:6973–6976Google Scholar
  183. Nagy LE, Diamond I, Casso DJ, Franklin C, Gordon AS (1990) Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. J Biol Chem 265:1946–1951Google Scholar
  184. Nazzarro JM, Seeger TF, Gardner EL (1981) Morphine differentially affects ventral tegmental and substantia nigra brain reward thresholds. Pharmacol Biochem Behav 14:325–331Google Scholar
  185. Negus SS, Henriksen SJ, Mattox A, Pasternak GW, Portoghese PS, Takemori AE, Weinger MB, Koob GF (1993) Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats. J Pharmacol Exp Ther 265:1245–1252Google Scholar
  186. Nestler E (1992) Molecular mechanisms of drug addiction. J Neurosci 12:2439–2450Google Scholar
  187. Nestler EJ, Hope BT, Widnell KL (1993) Drug addiction: a model for the molecular basis of neural plasticity. Neuron 11:995–1006Google Scholar
  188. Nides MA, Rakos RF, Gonzales D, Murray RP, Tashkin DP, Bjornson-Benson W, Lindgren P, Connett JE (1995) Predictors of initial smoking cessation and relapse through the first two years of the Lung Health Study. J Consult Clin Psychol 63:60–69Google Scholar
  189. O'Brien CP, Nace EP, Mintz J, Meyers AL, Ream N (1980) Follow-up of Vietnam veterans. I. Relapse to drug use after Vietnam service. Drug Alcohol Depend 5:333–340Google Scholar
  190. O'Brien CP, Childress AR, McLellan AT, Ehrman R (1992) A learning model of addiction. In: O'Brien CP, Jaffe J (eds) Advances in understanding the addictive states. Raven Press, New York, pp 157–177Google Scholar
  191. O'Malley SS, Jaffe AJ, Chang G, et al (1992) Naltrexone and coping skills therapy for alcohol dependence. Arch Gen Psychiatry 49:881–887Google Scholar
  192. Paille FM, Guelfi JD, Perkins AC, Royer RJ, Steru L, Parot P (1995) Double-blind randomised multicenter trial of acamprosate in maintaining abstinence from alcohol. Alcohol Alcoholism 30:239–247Google Scholar
  193. Parsons LH, Koob GF, Weiss F (1993) Extracellular serotonin and dopamine in the nucleus accumbens following unlimited access to cocaine self-administration. Soc Neurosci Abstr 19:759.2, p 1856Google Scholar
  194. Parsons LH, Koob GF, Weiss F (1995) Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Exp Pharmacol Ther 274:1182–1191Google Scholar
  195. Peng X, Gerzahich V, Anand R, Whiting PJ, Lindstrom J (1994) Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol 46:523–530Google Scholar
  196. Pentz MA, Dwyer DH, Mackinnon DP, Flay BR, Hansen WB, Wang EYI, Jonson CA (1989) A multicommunity trial for primary prevention of adolescent drug abuse. J Am Med Asso 261:3259–3266Google Scholar
  197. Pettit HO, Justice JB (1989) Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacol Biochem Behav 34: 899–904Google Scholar
  198. Pettit HO, Ettenberg A, Bloom FE, Koob GF (1984) Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology 84: 167–173Google Scholar
  199. Phillips AG, Blaha CD, Fibiger HC (1989) Neurochemical correlates of brain-stimulation reward measured by ex vivo and in vivo analyses. Neurosci Biobehav Rev 13: 99–104Google Scholar
  200. Phillips AG, Pfaus JG, Blaha CD (1991) Dopamine and motivated behaviour: Insights provided by in vivo analyses. In: Willner P, Scheel-Kruger J (eds) The mesolimbic dopamine system: from motivation to action. Wiley, London, pp 199–224Google Scholar
  201. Phillips GD, Robbins TW, Everitt BJ (1994a) Meso-accumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer. Psychopharmacology 114: 345–359Google Scholar
  202. Phillips GD, Robbins TW, Everitt BJ (1994b) Bilateral intra-acc-umbens self-administration of d-amphetamine: antagonism with intra-accumbens SCH-23390 and sulpiride. Psychopharmacology 114: 477–485Google Scholar
  203. Phillips GD, Howes S, Whitelaw R, Wilkinson LS, Robbins TW, Everitt BJ (1994c) Isolation rearing enhances the locomotor response to cocaine and a novel environment, but impairs intravenous self-administration of cocaine. Psychopharmacology 115: 407–418Google Scholar
  204. Phillips GD, Whitelaw R, Howes S, Robbins TW, Everitt BJ (1994d) Isolation rearing impairs the reinforcing efficacy of intravenous cocaine or intra-accumbens d-amphetamine: impaired response to intra-accumbens D1 and D2/3 dopamine receptor antagonists. Psychopharmacology 115: 419–429Google Scholar
  205. Phillips TJ, Crabbe JC, Metten P, Belknap JK (1994) Localization of genes affecting alcohol drinking in mice. Alcohol Clin Exp Res 18: 931–941Google Scholar
  206. Phillips TJ, Huson M, Gwiazdon C, Burkhart-Kasch S, Shen EH (1995) Effects of acute and repeated ethanol exposures on the locomotor activity of BXD recombinant inbred mice. Alcohol Clin Exp Res 19: 269–278Google Scholar
  207. Piazza PV, Deminiere J-M, LeMoal M, Simon H (1989) Factors that predict individual vulnerability to amphetamine self-administration. Science 245: 1511–1513Google Scholar
  208. Piazza PV, Deminiere J-M, Le Moal M, Simon H (1990) Stress-and pharmacologically-induced behavioural sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res 514: 22–26Google Scholar
  209. Piazza PV, Deroche V, Deminiere J-M, Maccari S, Le Moal M, Simon H (1993) Corticosterone in the range of stress-induced levels possesses reinforcing properties: implications for sensation-seeking behaviors. Proc Natl Acad Sci USA 90: 11738–11742Google Scholar
  210. Pickens RW, Johanson CE (1992) Craving: consensus of status and agenda for future research. Drug Alcohol Depend 30: 127–131Google Scholar
  211. Plomin R, McClearn GE, Gora-Maslak G (1991) Quantitative trait loci and psychopharmacology. J Psychopharmacol 5: 1–9Google Scholar
  212. Portans I, White JM, Staiger PK (1989) Acute tolerance to alcohol: changes in subjective effects among social drinkers. Psychopharmacology 97: 365–369Google Scholar
  213. Potokar J, Nutt DJ (1994) Anxiolytic potential of benzodiazepine receptor partial agonists. CNS Drugs 1: 305–315Google Scholar
  214. Powell DH (1973) A pilot study of occasional heroin users. Arch Gen Psychiatry 28: 586–594Google Scholar
  215. Preston KL, Bigelow GE (1991) Subjective and discriminative effects of drugs. Behav Pharmacol 2: 293–313Google Scholar
  216. Radlow R (1994) A quantitative theory of acute tolerance to alcohol. Psychopharmacology 114: 1–8Google Scholar
  217. Rasmussen K, Beitner-Johnson DB, Krystal JH, Aghajanian GK, Nestler EJ (1990) Opiate withdrawal and the rat locus coeruleus: behavioural, electrophysiological, and biochemical correlates. J Neurosci 10: 2308–2317Google Scholar
  218. Reisenzein R (1983) The Schachter theory of emotion: two decades later. Psychol Bull 94: 239–264Google Scholar
  219. Robbins TW, Cador M, Taylor JR, Everitt BJ (1989) Limbic-striatal interactions in reward-related processes. Neurosc Biobehav Rev 13: 155–162Google Scholar
  220. Robbins TW, Everitt BJ (1992) Functions of dopamine in the dorsal and ventral striatum. Semin Neurosci 4: 119–127Google Scholar
  221. Robbins TW, Watson BA, Gaskin M, Ennis C (1983) Contrasting interactions of pipradrol, d-amphetamine, cocaine analogues, apomorphine and other drugs with conditioned reinforcement. Psychopharmacology 80: 113–119Google Scholar
  222. Robbins TW, Mittleman G, O'Brien J, Winn, P (1990) Neuropsychological significance of stereotypy induced by stimulant drugs. In: Cooper SJ, Dourish C (eds) Neurobiology of behavioural stereotypy. Oxford University Press, Oxford, pp 25–63Google Scholar
  223. Roberts DC, Loh EA, Baker GB, Vickers G (1994) Lesions of central serotonin systems affect responding on a progressive ratio schedule reinforced either by intravenous cocaine or by food. Pharmacol Biochem Behav 49: 177–182Google Scholar
  224. Roberts DCS, Corcoran ME, Fibiger HC (1977) On the role of ascending catecholaminergic systems in intravenous cocaine self-administration of cocaine. Pharmacol Biochem Behav 6: 615–620Google Scholar
  225. Robins LN, Davis DH, Durco DN (1974) How permanent was Vietnam drug addiction? Am J Public Health 64: 38–43Google Scholar
  226. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18: 247–291Google Scholar
  227. Robledo P, Koob GF (1993) Two discrete nucleus accumbens projection areas differentially mediate cocaine self-administration in the rat. Behav Brain Res 55: 159–166Google Scholar
  228. Rossetti ZL, Hmaidan Y, Gess GL (1992a) Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence. Eur J Pharmacol 221: 227–234Google Scholar
  229. Rossetti ZL, Melis F, Carboni S, Diana M, Gessa GL (1992b) Alcohol withdrawal in rats is associated with a marked fall in extraneuronal dopamine. Alcohol Clin Exp Res 16: 529–532Google Scholar
  230. Rothman R, Gorelick D, Baumann M, Cuo X, Herning R, Pickworth W, Gendron T, Keoppl B, Thomson L, Henningfield J (1984) Lack of evidence for context-dependent cocaine-in-duced sensitization in humans: preliminary studies. Pharmacol Biochem Behav 49: 583–588Google Scholar
  231. Rothman RB, Mele A, Reid AA, Akunne HC, Greig N, Thurkauf A, de Costa BR, Rice KC, Pert A (1991) GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine. Pharmacol Biochem Behav 40: 387–397Google Scholar
  232. Rounsaville BJ, Weissman MM, Wilber CH, Kleber HD (1982) Pathways to opiate addiction: an evaluation of differing antecedents. Br J Psychiatry 141: 437–446Google Scholar
  233. Russell MAH (1990) Nicotine intake and its control over smoking. In: Wonnacott S, Russell MAH, Stolerman IP (eds) Nicotine psychopharmacology: molecular, cellular and behavioural aspects. Oxford Science Publications, Oxford, pp 374–418Google Scholar
  234. Russell MAH, Jarvis M, Jones G, Feyerabend C (1990) Nonsmokers show acute tolerance to subcutaneous nicotine. Psychopharmacology 102: 56–58Google Scholar
  235. Sahakian BJ, Jones G, Levy R, Gray J, Warburton D (1989) The effects of nicotine on attention, information processing and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry 154: 797–800Google Scholar
  236. Samson HH, Roehrs TA, Tolliver GA (1982) Ethanol reinforced responding in the rat: a concurrent analysis using sucrose as the alternate choice. Pharmacol Biochem Behav 17: 333–339Google Scholar
  237. Sanderson EM, Drasdo AL, McCrea K, Wonnacott S (1993) Upregulation of nicotinic receptors following continuous infusion of nicotine is brain region-specific. Brain Res 617: 349–352Google Scholar
  238. Schachter S, Singer W (1962) Cognitive, social and physiological determinants of emotional states. Psychol Rev 69: 378–399Google Scholar
  239. Schenk S, Hunt T, Cole L, Amit Z (1983) Isolation vs. grouped housing in rats: differential effects of low doses of heroin in the place preference paradigm. Life Sci 32: 1129–1134Google Scholar
  240. Schenk S, Hunt T, Malovechko R, Robertson A, Klukowski G, Amit Z (1986) Differential effects of isolation housing on the conditioned place preference produced by cocaine and amphetamine. Pharmacol Biochem Behav 24: 1793–1796Google Scholar
  241. Schuckit MA (1984) Subjective responses to alcohol in sons of alcoholics and control subjects. Arch Gen Psychiatry 41: 879–884Google Scholar
  242. Schuckit MA (1985) Ethanol induced changes in body sway in men at high alcoholism risk. Arch Gen Psychiatry 42: 375–379Google Scholar
  243. Schuckit MA (1987) Biological vulnerability to alcoholism. J. Consult Clin Psychol 55: 301–309Google Scholar
  244. Schuckit MA (1994) Low level of response to alcohol as a predictor of future alcoholism. Am J Psychiatry 151: 184–189Google Scholar
  245. Schulteis G, Markou A, Gold LH, Stinus L, Koob GF (1994) Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther 271: 1391–1398Google Scholar
  246. Schulteis G, Markou A, Cole M, Koob GF (1996) Decreased brain reward processes by ethanol withdrawal. Proc Natl Acad Sci USA (in press)Google Scholar
  247. Schultz W (1992) Activity of dopamine neurons in the behaving primate. Semin Neurosci 4: 129–138Google Scholar
  248. Schultz W, Apicella P, Ljungberg T (1993) Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J Neurosci 13: 900–913Google Scholar
  249. Schuster CR, Johanson CE (1973) Behavioural analysis of opiate dependence. In: Fisher S, Freedman AM (eds) Opiate addiction: origins and treatment. Winston, Washington DC, pp 77–92Google Scholar
  250. Schuster CR, Johanson CE (1981) Animal models of self-administration. In: Adv Substance Abuse 2: 219–297Google Scholar
  251. Schuster CR, Kilbey MM (1992) Prevention of drug abuse. In: Last J, Wallace R (eds) Maxcy-Rosenau-Last Public Health and preventative Medicine. 13th edn. Appleton and Lange, Connecticut, pp 769–786Google Scholar
  252. Schuster CR, Dockens WS, Woods JH (1966) Behavioural variables affecting the development of amphetamine tolerance. Psychopharmacologia (Berl) 9: 170–182Google Scholar
  253. Schuster CR, Fischman MW, Johanson CE (1981) Internal stimulus control and the subjective effects of drugs. NIDA Res Monogr 37: 116–129Google Scholar
  254. Schuster CR, Greenwald MK, Johanson CE, Heishman S (1995) Measurement of drug craving during naloxone-precipitated withdrawal in methadone-maintained volunteers. Exp Clin Psychopharmacol 3: 424–431Google Scholar
  255. Segal DS, Geyer MA, Schuckit MA (1981) Stimulant-induced psychosis: an evaluation of animal models. In: Youdim MBH, Lovenberg W, Sharman DF, Lagnado JR (eds) Essays in neurochemistry and neuropharmacology, vol 5. Wiley, New YorkGoogle Scholar
  256. Sellars EM, Higgins GA, Sobell MB (1992) 5-HT and alcohol abuse. TIPS 13: 69–75Google Scholar
  257. Shaham Y, Stewart J (1995) Stress reinstates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal. Psychopharmacology 119: 334–341Google Scholar
  258. Shaham Y, Rodaros D, Stewart J (1994) Reinstatement of heroinreinforced behavior following long-term extinction: implications for the treatment of relapse to drug taking. Behav Pharmacol 5: 360–364Google Scholar
  259. Shaw GK, Waller S, Majumdar SK, Alberts JL, Latham CJ, Dunn G (1994) Tiapride in the prevention of relapse in recently detoxified alcoholics. Br J Psychiatry 165: 515–523Google Scholar
  260. Shippenberg TS, Heidbreder CH (1995) Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics. J Pharmacol Exp Ther 272: 808–815Google Scholar
  261. Shoaib M, Stolerman IP (1992) MK801 attenuates behavioural adaptation to chronic nicotine administration in rats. Br J Pharmacol 105: 514–515Google Scholar
  262. Siegel S (1979) The role of conditioning in drug tolerance and addiction. In: Keehn JD (ed) Psychopathology in animals: research and treatment implications. Academic, New York, pp 143–168Google Scholar
  263. Sills TL, Vaccarino FJ (1994) Individual differences in sugar intake predict the locomotor response to acute and repeated amphetamine administration. Psychopharmacology 116: 1–8Google Scholar
  264. Silverman K, Kirby KC, Griffiths RR (1994a) Modulation of drug reinforcement by behavioural requirements following drug ingestion. Psychopharmacology 114: 243–247Google Scholar
  265. Silverman K, Mumford GK, Griffiths RR (1994b) Enhancing caffeine reinforcement by behavioural requirements following drug ingestion. Psychopharmacology 114: 424–432Google Scholar
  266. Smith A, Parsons LH, Merlo Pich E, Hyytia P, Schulteis G, Lorang MT, Yackey MF, Koob GF, Weiss F (1994) Ethanol modifies extracellular levels of dopamine, serotonin and CRF in the limbic forebrain: studies in rats with different histories of ethanol exposure. Soc Neurosci Abstr 20: 661.4Google Scholar
  267. Smith JE, Lane JD (1983) Brain neurotransmitter turnover correlated with morphine self-administration. In: Smith JE, Lane JD (eds) The neurobiology of opiate reward processes, Amsterdam, Elsevier, pp 361–402Google Scholar
  268. Solomon RL, Corbit JD (1973) An opponent-process theory of motivation. II. Cigarette addiction. J Abnorm Psychol 81: 158–171Google Scholar
  269. Solomon RL, Corbit JD (1974) An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychol Rev 81: 119–145Google Scholar
  270. Sorg BA, Kalivas PW (1993) Behavioural sensitization to stress and psychostimulants: role of dopamine and excitatory amino acids in the meso-corticolimbic system. Semin Neurosci 5: 343–350Google Scholar
  271. Spealman RD (1979) Behaviour maintained by termination of a schedule of self-administered cocaine. Science 204: 1231–1233Google Scholar
  272. Spyraki C, Fibiger HC (1988) A role for the mesolimbic dopamine system in the reinforcing properties of diazepam. Psychopharmacology 94: 133–137Google Scholar
  273. Spyraki C, Fibiger HC, Phillips AG (1982) Attenuation by haloperidol of place preference conditioned using food reinforcement. Psychopharmacology 77: 379–382Google Scholar
  274. Stephens DN, Schneider HH, Weidmann R, Zimmermann L (1988) Decreased sensitivity to benzodiazepine receptor agonists and increased sensitivity to inverse agonists following chronic treatments: evidence for separate mechanisms. Adv Biochem Psychopharmacol 45: 337–354Google Scholar
  275. Stewart J, Badiani A (1993) Tolerance and sensitization to the behavioural effects of drugs. Behav Pharmacol 4: 289–312Google Scholar
  276. Stewart J, Wit H de (1987) Reinstatement of drug-taking behaviour as method of assessing incentive motivational properties of drugs. In: Bozarth MA (ed) Methods of assessing incentive motivational properties of drugs. Springer, New York Berlin Heidelberg, pp 211–227Google Scholar
  277. Stolerman IP (1990) What animal work may tell. Commentary on “Withdrawal symptoms and alcohol dependence: fruitful mysteries” by Griffith Edwards. Br J Addict 85: 1251–1252Google Scholar
  278. Stolerman IP (1992) Drugs of abuse: behavioural principles, methods and terms. Trends Pharmacol Sci 13: 170–176Google Scholar
  279. Stolerman IP, Jarvis MJ (1995) The scientific case that nicotine is addictive. Psychopharmacology 117: 2–11Google Scholar
  280. Stolerman IP, Goldfarb T, Fink R, Jarvik ME (1973) Influencing cigarette smoking with nicotine antagonists Psychopharmacologia (Berl) 28: 247–259Google Scholar
  281. Strang J, Seivewright N, Farrell M (1992) Intravenous and other novel abuse of benzodiazepines: the opening of Pandora's box? Br J Addict 87: 1373–1375Google Scholar
  282. Swedberg MDB, Henningfield JE, Goldberg SR (1990) Nicotine dependency: animal studies. In: Wonnacott S, Russell MAH, Stolerman IP (eds) Nicotine psychopharmacology: molecular, cellular and behavioural aspects. Oxford Science Publications, Oxford, pp 38–76Google Scholar
  283. Szostak C, Finlay JM, Fibiger HC (1987) Intravenous self-administration of the short-acting benzodiazepine midazolam in the rat. Psychopharmacology 26: 1673–1676Google Scholar
  284. Tabakoff B, Hoffman PL (1992) Alcohol: neurobiology. In: Lowenstein JH, Ruiz P, Millman RB (eds) Substance abuse: a comprehensive textbook. Williams and Wilkins, Baltimore, pp 152–185Google Scholar
  285. Taioli E, Wynder EL (1991) The importance of age of starting smoking. New Engl J Med 325: 968–969Google Scholar
  286. Taylor DN (1995) Clinical and experimental evaluation of cranial TENS in the US: a review. Acupuncture Electrother Res 20:117–132Google Scholar
  287. Ternes JW, Ehrman RN, O'Brien CP (1985) Nondependent monkeys self-administer hydromorphone. Behav Neurosci 99:583–588Google Scholar
  288. Tidey J, Miczek K (1994) Threat of attack increases in vivo dopamine release in prefrontal cortex and nucleus accumbens. Neurosci Abstr 20:1443Google Scholar
  289. Tiffany ST (1990) A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes. Psychol Rev 97:147–168Google Scholar
  290. Tiffany ST, Drobes DJ, Cepeda-Benito A (1992) Contribution of associative and non-associative processes to the development of morphine tolerance. Psychopharmacology 109:185–190Google Scholar
  291. Tiffany ST, Singleton E, Haertzen C, Henningfield JE (1993) The development of a cocaine craving questionnaire. Drug Alcohol Depend 34:19–28Google Scholar
  292. Uhlenbuth EH, Johanson CE, Kilgore K, Kobara SC (1981) Drug preferences and mood in humans: preference for d-amphetamine and subjective characteristics. Psychopharmacology 74:191–194Google Scholar
  293. US Congress, Office of Technology Assessment (1994) Technologies for understanding and preventing substance abuse and addiction. OTA-EHR-597, US Government Printing Office, Washington DCGoogle Scholar
  294. US Department of Health and Human Services (1988) The health consequences of smoking: nicotine addiction. Report of the Surgeon General (CDC 89-8411), US Government Printing Office, Washington DCGoogle Scholar
  295. US Department of Health and Human Services (1990) The health benefits of smoking cessation. A report of the Surgeon General (CDC 90-8416), US DHHS, Center for Disease Control, MarylandGoogle Scholar
  296. US Department of Health and Human Services (1989) Eighth special report to the US Congress on alcohol and health. NIH Publication no. 94-3699Google Scholar
  297. Valadez A, Schenk S (1994) Persistence of the ability of amphetamine preexposure to facilitate acquisition of cocaine self-administration. Pharmacol Biochem Behav 47:203–205Google Scholar
  298. Van Der Kooy D (1987) Place conditioning: a simple and effective method for assessing the motivational properties of drugs. In: Bozarth M (ed) Methods of assessing the reinforcing properties of abused drugs. Springer, New York Berlin Heidelberg, pp 229–240Google Scholar
  299. Vellucci SV, Turner P, Everitt BJ (1988) The discriminative stimulus produced by pentylenetetrazol: effects of systemic anxiolytics and anxiogenics, aggressive defeat and midazolam or muscimol infused into the amygdala. J Psychopharmacol 2:80–93Google Scholar
  300. Virkkunen M, Rawlings R, Tokola R, Poland RE, Guidotti A, Nemeroff C, Bissette G, Kalogeras K, Koronen S-L, Linnoila M (1994) CSF biochemistries, glucose metabolism, and diurnal activity rhythms, in alcoholics, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry 51:20–28Google Scholar
  301. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876–880Google Scholar
  302. Wafford KA, Burnett DM, Leidenheimer NJ, Burt DR, Wang JB, Kofuji P, Dunwiddie TV, Harris RA, Sikela M (1991) Ethanol sensitivity of the GABAA receptor expressed inXenopus oocytes requires 8 amino acids contained in the γ2L subunit. Neuron 7:27–33Google Scholar
  303. Wahlestedt C (1994) Antisense oligonucleotide strategies in neuropharmacology. Trends Pharmacol Sci 14:42–46Google Scholar
  304. Walker WO III (1994) US narcotics foreign policy in the twentieth century: an analytical overview. In: Perl R (ed) Drugs and foreign policy: a critical review. Westview Press, Boulder, Colo, pp 7–40Google Scholar
  305. Wang JB, Johnson PS, Persico A, Hawkins AL, Griffin CA, Uhl GR (1994) Human μ opiate receptor: cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett 338:217–222Google Scholar
  306. Weiss F, Markou A, Lorang MT, Koob GF (1992) Basal dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res 593:314–318Google Scholar
  307. White NM (1989) A functional hypothesis concerning the striatal matrix and patches: mediation of S-R memory and reward. Life Sci 45:1943–1957Google Scholar
  308. White NM (1996) Addictive drugs as reinforcers: multiple partial actions on memory systems. Addiction (in press)Google Scholar
  309. White NM, Hiroi N (1993) Amphetamine conditioned cue preference and the neurobiology of drug seeking. Semin Neurosci 5:329–336Google Scholar
  310. Whitelaw RB, Markou A, Robbins TW, Everitt, BJ (1996) Excitotoxic lesions of the basolateral amygdala inpair the acquisition of cocaine-seeking behaviour under a second-order schedule of reinforcement. Psychopharmacology (in press)Google Scholar
  311. Whittington MA, Siarey RJ, Patch TL, Butterworth AR, Dolin SJ and Little HJ (1991) Chronic dihydropyridine treatment can reverse the behavioural consequences and prevent the adaptations to chronic ethanol. Br J Pharmacol 103:1669–1676Google Scholar
  312. Whittington MA, Little HJ, Lambert JDC (1992) Changes in intrinsic inhibition in isolated hippocampal slices during ethanol withdrawal: lack of correlation with withdrawal hyperexcitability. Br J Pharmacol 107:521–527Google Scholar
  313. WHO (1992) International Classification of Diseases, 10th edn. World Health Organization, GenevaGoogle Scholar
  314. Wikler A (1965) Conditioning factors in opiate addiction and relapse. In: Willner DI, Kassebaum GG (eds) Narcotics. McGraw-Hill, New York, pp 7–21Google Scholar
  315. Wikler A, Pescor FT (1967) Classical conditioning of a morphine abstinence phenomenon, reinforcement of opioid drinking behaviour and “relapse” in morphine-addicted rats. Psychopharmacologia (Berl) 10:255–284Google Scholar
  316. Wilkinson LS, Killcross AS, Humby T, Hall FS, Torres E, Robbins TW (1994) Social isolation produces developmentally specific deficits in pre-pulse inhibition of the acoustic startle response but does not change latent inhibition. Neuropsychopharmacology 10:61–72Google Scholar
  317. Wilson JR, Erwin VG, DeFries JC, Petersen DJ, Cole-Harding S (1984) Ethanol dependence in mice: direct and correlated responses to ten generations of selective breeding. Behav Genet 14:235–256Google Scholar
  318. Wise R (1982) Neuroleptics and operant behavior: the anhedonia hypothesis. Behav Brain Sci 5:39–87Google Scholar
  319. Wise RA (1993) In vivo estimates of extracellular dopamine and dopamine metabolite levels during intravenous cocaine or heroin self-administration. Semin Neurosci 5:337–342Google Scholar
  320. Wit H de, Chutuape MA (1993) Increased ethanol choice in social drinkers following ethanol preload. Behav Pharmacol 4:29–36Google Scholar
  321. Wolf ME, White FJ, Hu X-T (1994) MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J Neurosci 14:1735–1745Google Scholar
  322. Wonnacott S (1990) The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol Sci 11:216–219Google Scholar
  323. Woods J, Schuster C (1968) Reinforcement properties of morphine, cocaine, and SPA as a function of unit dose. Int J Addict 3:231–237Google Scholar
  324. Woods J, Katz J, Winger G (1992) Benzodiazepines use, abuse and consequences. Pharmacol Rev 44:151–347Google Scholar
  325. Woolverton WL, Cervo L, Johanson CE (1984) Effects of repeated methamphetamine self-adminstration in rhesus monkeys. Pharmacol Biochem Behav 21:737–741Google Scholar
  326. Xu M, Hu X-T, Cooper DC, Moratalla R, Graybiel AM, White FJ, Tonegawa S (1994a) Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor deficient mice. Cell 79:945–955Google Scholar
  327. Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM, Tonegawa S (1994b) Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopaminemediated behavioral responses. Cell 79:729–742Google Scholar
  328. Yamaguchi K, Kandel DB (1984) Patterns of drug use from adolescence to young adulthood. III. Predictors of progression. Am J Public Health 74:673–681Google Scholar
  329. Yanagita T (1973) An experimental framework for evaluation of dependence liability of various types of drugs in monkeys. Bull Narc 25:57–64Google Scholar
  330. Young AM, Goudie AJ (1995) Adaptive processes regulating tolerance to the behavioral effects of drugs. In: Bloom FE, Kupfer D (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 733–742Google Scholar
  331. Young AM, Herling S (1986) Drugs as reinforcers. In: Goldberg SR, Stolerman IP (eds) Behavioral analysis of drug dependence. Academic Press, Orlando, pp 9–67Google Scholar
  332. Young PT, Chaplin JP (1945) Studies of food preference, appetite and dietary habit: palatability and appetite in relation to bodily need. Comp Psychol Monogr 18 (3, whole no. 95)Google Scholar
  333. Zahm DS, Brog JS (1992) On the significance of subterritories in the “accumbens” part of the rat ventral striatum. Neuroscience 50:751–767Google Scholar

Copyright information

© Springer-Verlag 1996

Authors and Affiliations

  • J. Altman
    • 1
  • B. J. Everitt
    • 2
  • T. W. Robbins
    • 2
  • S. Glautier
    • 3
  • A. Markou
    • 4
  • D. Nutt
    • 5
  • R. Oretti
    • 6
  • G. D. Phillips
    • 7
  1. 1.LondonUK
  2. 2.Department of Experimental PsychologyUniversity of CambridgeCambridgeUK
  3. 3.Department of PsychologyUniversity of SwanseaSwanseaUK
  4. 4.Department of NeuropharmacologyThe Scripps Research InstituteLa JollaUSA
  5. 5.Departments of Pharmacology and PsychiatryUniversity of BristolBristolUK
  6. 6.Department of PsychiatryUniversity of CardiffCardiffUK
  7. 7.Department of PsychologyUniversity of YorkYorkUK

Personalised recommendations